Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. ...

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

The one thing that experts, along with vaccine makers, can agree on is that low vaccination rates put people at risk of getting severe Covid infections. ...

Activist investor Nelson Peltz launches Disney proxy fight, seeks multiple board seats

Nelson Peltz and his firm, Trian, are seeking multiple seats on Disney's board, triggering a proxy fight....

Pending home sales drop to a record low, even worse than during the financial crisis

Mortgage rates in October rose sharply, with the average on the 30-year fixed loan briefly eclipsing 8%....

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

The lawsuits come as Novo Nordisk grapples with shortages of Wegovy and Ozempic in the U.S. due to skyrocketing demand. ...

Ulta Beauty shares pop as sales climb 6%

Ulta Beauty reported a jump in sales year over year and said its chief financial officer would retire in April....

Mars, accused of using child labor in its supply chain, says it aims to end the practice

Children in Ghana are harvesting cocoa used in Mars' M&M's and Snickers, according to a CBS News report....

'Sound of Freedom' studio looks to build on crowdfunding success with new film 'The Shift'

Angel Studios' "The Shift" was crowdfunded by 6,000 investors. It arrives in theaters Friday. ...

Disney CEO Bob Iger says company's movies have been too focused on messaging

Disney CEO Bob Iger acknowledged his company's movies have been too focused on messaging rather than strong storytelling....

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of the buyout....